Download this eGuide to learn more.
In today’s rapidly evolving cell and gene therapy landscape where 90% of production is outsourced, manufacturers face unprecedented challenges in scaling from clinical to commercial production. With current capacity meeting only 5%-10% of projected commercial needs, the industry demands innovative solutions.
This comprehensive guide reveals how digital transformation can revolutionize your cell and gene therapy manufacturing process, ensuring therapies reach patients faster without compromising quality or compliance. Learn actionable insights on how to:
- Leverage the latest digital innovations to overcome scalability barriers and bridge the gap between promising pipeline and commercial products
- Eliminate manual processes that cause errors, delays, and compliance risks while significantly reducing batch review times
- Navigate the unique GMP challenges of personalized “batch-of-one” therapies
- And more
Offered Free by: MasterControl
See All Resources from: MasterControl
